Impurities and instability are challenges for all drugs, but a growing range of technological tools are helping drug developers and manufacturers minimize them.

Next-generation sequencing enhances a biologics manufacturer's ability to detect and identify unknown or unexpected contaminants.

It wasn’t always this way. Leveraging AI in drug development is not only thanks to growing access to semiconductor chips, but also how technology has allowed for quick and now cheap ways of mapping ...

The killing of the United Healthcare CEO, assassination of Charlie Kirk and attempted assassination of Trump and many other ...

The company is already engaged in pilot production at its Vietnamese facility and anticipates scaling output in response to growing market interest.

Representatives from EU institutions, the Polish government, innovative and generic pharmaceutical companies, and academia discussed how to ensure strategic dru ...